Current Neuro-Oncology
Volume
25 Number 18
30 September 2023
Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 18, 30 September
Wegener E, Horsley P, Wheeler H,
Jayamanne D, Kastelan M, Guo L, Brown C, Back
M.
Leptomeningeal
neuraxis relapse in glioblastoma is an uncommon but not
rare
event associated with poor outcome.
BMC
Neurol. 2023 Sep 15;23(1):328∟.
doi: 10.1186/s12883-023-03378-1∟.
PMID: 37715122∟.
Observational study. ˍ
Alanzi AK, Hakmi S, Adeel S,
Ghazzal SY.
Anesthesia
for awake craniotomy: a case
report.
J Surg
Case Rep. 2023 Sep 16;2023(9):rjad521∟.
doi: 10.1093/jscr/rjad521∟.
PMID: 37724066∟.
Case report. ˍ
Johnson TS, MacDonald TJ,
Pacholczyk R, Aguilera D, Al-Basheer A, Bajaj M, Bandopadhayay P,
Berrong Z, Bouffet E, Castellino RC, Dorris K, Eaton BR,
Esiashvili N, Fangusaro JR, Foreman N, Fridlyand D, Giller C,
Heger IM, Huang C, Kadom N, Kennedy EP, Manoharan N, Martin W,
McDonough C, Parker RS, Ramaswamy V, Ring E, Rojiani A, Sadek RF,
Satpathy S, Schniederjan M, Smith A, Smith C, Thomas BE, Vaizer R,
Yeo KK, Bhasin MK, Munn DH.
Indoximod-based
chemo-immunotherapy for pediatric brain tumors: a
first-in-children phase 1 trial.
Neuro
Oncol. 2023 Sep 16:noad174∟.
doi: 10.1093/neuonc/noad174∟.
PMID: 37715730∟.
Interventional study. ˍ
Stritzelberger J, Gesmann A,
Fuhrmann I, Balk S, Reindl C, Madžar D, Uhl M, Welte
TM, Brandner S, Eisenhut F, Dörfler A, Coras R, Adler W,
Schwab S, Putz F, Fietkau R,
Distel L, Hamer HM.
Status
epilepticus in patients with glioblastoma:
Clinical
characteristics, risk factors, and epileptological
outcome.
Seizure.
2023 Sep 16;112:48-53∟.
doi: 10.1016/j.seizure.2023.09.014∟.
PMID: 37748366∟.
Observational study. ˍ
Marques Da Costa ME, Zaidi S,
Scoazec JY, Droit R, Lim WC, Marchais A, Salmon J,
Cherkaoui S, Morscher RJ, Laurent A, Malinge S, Mercher T,
Tabone-Eglinger S, Goddard
I, Pflumio F, Calvo J, Redini F, Entz-Werlé N, Soriano A,
Villanueva A, Cairo S,
Chastagner P, Moro M, Owens C, Casanova M, Hladun-Alvaro R,
Berlanga P, Daudigeos-Dubus
E, Dessen P, Zitvogel L, Lacroix L, Pierron G, Delattre O,
Schleiermacher G, Surdez D,
Geoerger B.
A
biobank of pediatric patient-derived-xenograft models in cancer
precision medicine trial MAPPYACTS for relapsed and
refractory
tumors.
Commun
Biol. 2023 Sep 18;6(1):949∟.
doi: 10.1038/s42003-023-05320-0∟.
PMID: 37723198∟.
Interventional study. ˍ
Rahman R, Trippa L, Lee EQ,
Arrillaga-Romany I, Fell G, Touat M, McCluskey C, Wiley
J, Gaffey S, Drappatz J, Welch MR, Galanis E, Ahluwalia MS, Colman
H, Nabors LB, Hepel J,
Elinzano H, Schiff D, Chukwueke UN, Beroukhim R, Nayak L,
McFaline-Figueroa JR, Batchelor TT,
Rinne ML, Kaley TJ, Lu-Emerson C, Mellinghoff
IK, Bi WL, Arnaout O, Peruzzi PP, Haas-Kogan D, Tanguturi S,
Cagney D, Aizer A, Doherty
L, Lavallee M, Fisher-Longden B, Dowling S, Geduldig J,
Watkinson F, Pisano W, Malinowski
S, Ramkissoon S, Santagata S, Meredith DM, Chiocca
EA, Reardon DA, Alexander BM, Ligon KL, Wen PY.
Inaugural
Results of the Individualized
Screening Trial of Innovative Glioblastoma Therapy: A Phase II
Platform
Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive
Randomization.
J
Clin Oncol. 2023 Sep 18:JCO2300493∟.
doi: 10.1200/JCO.23.00493∟.
PMID: 37722087∟.
Interventional study˰ ˍ
Zaed I, Marchi F, Milani D, Cabrilo
I, Cardia A.
Role
of Enhanced Recovery after
Surgery (ERAS) Protocol in the Management of Elderly Patients with
Glioblastoma.
J
Clin Med. 2023 Sep 18;12(18):6032∟.
doi: 10.3390/jcm12186032∟.
PMID: 37762972∟.
Observational study. ˍ
Zhou W, Zhang H, An X, Li C, Gong
J, Liu W, Sun T, Zhao F, Tian YJ.
A
nomogram
for predicting post-operative hydrocephalus in children with
medulloblastoma.
Neurosurg
Rev. 2023 Sep 18;46(1):246∟.
doi: 10.1007/s10143-023-02156-4∟.
PMID: 37723329∟.
Observational study˰ ˍ
Bonanno M, Bourque CJ, Robichaud
LA, Levesque A, Lacoste-Julien A, Rondeau É, Dubé É,
Leblanc M, Bertrand MC, Provost C, Desjardins L, Sultan
S.
Prioritizing
Solutions and Improving Resources among Young Pediatric Brain
Tumor Survivors: Results of an Online Survey.
Curr
Oncol. 2023 Sep 19;30(9):8586-8601∟.
doi: 10.3390/curroncol30090623∟.
PMID: 37754538∟.
Observational study. ˍ
*
Chandar JS, Bhatia S, Ingle S,
Mendez Valdez MJ, Maric D, Seetharam D, Desgraves
JF, Govindarajan V, Daggubati L, Merenzon M, Morell A, Luther E,
Saad AG, Komotar RJ, Ivan
ME, Shah AH.
Laser
Interstitial Thermal Therapy Induces
Robust
Local Immune Response for Newly Diagnosed Glioblastoma with
Long-term Survival
and Disease Control.
J
Immunother. 2023 Sep 19∟.
doi: 10.1097/CJI.0000000000000485∟.
PMID: 37727953∟.
Case report˰ ˍ
Fan P, Xia J, Zhou M, Zhuo C, He
H.
Development
and validation of a
personalized
classifier to predict the prognosis and response to immunotherapy
in
glioma based on glycolysis and the tumor microenvironment.
PeerJ.
2023 Sep 19;11:e16066∟.
doi: 10.7717/peerj.16066∟.
PMID: 37744243∟.
Observational study. ˍ
Farzana W, Basree MM, Diawara N,
Shboul ZA, Dubey S, Lockhart MM, Hamza M, Palmer
JD, Iftekharuddin KM.
Prediction
of Rapid Early Progression and Survival
Risk
with Pre-Radiation MRI in WHO Grade 4 Glioma Patients.
Cancers
(Basel). 2023 Sep
19;15(18):4636∟.
doi: 10.3390/cancers15184636∟.
PMID: 37760604∟.
Observational study. ˍ
Gibson D, Ravi A, Rodriguez E,
Chang S, Oberheim Bush N, Taylor J, Clarke J, Solomon D, Scheffler
A, Witte J, Lambing H, Okada H, Berger M, Chehab F, Butowski
NA.
Quantitative
analysis of MGMT
promoter
methylation in glioblastoma suggests nonlinear prognostic
effect.
Neurooncol
Adv. 2023 Sep 19;5(1):vdad115∟.
doi: 10.1093/noajnl/vdad115∟.
PMID: 37899778∟.
Observational study. ˍ
Castelli B, Fonte C, Guidi M,
Tellini M, Di Nicola M, Iacono A, Buccoliero AM, Greto D, Genitori
L, Sardi I.
Bevacizumab-Irinotecan
combination therapy in recurrent low-grade glioma, previously
treated with chemo-radiotherapy: a case report.
Front
Oncol. 2023 Sep 20;13:1244628∟.
doi: 10.3389/fonc.2023.1244628∟.
PMID: 37799478∟.
Case report. ˍ
*
D'Onofrio G, Icolaro N, Fazzari E,
Catapano D, Curcio A, Izzi A, Manuali A, Bisceglia
G, Tancredi A, Marchello V, Recchia A, Tonti MP, Pazienza L,
Carotenuto V, Bonis C, Savarese L,
Gaudio AD, Gorgoglione LP.
Real-Time
Neuropsychological
Testing (RTNT) and Music Listening during Glioblastoma
Excision
in Awake Surgery: A Case Report.
J
Clin Med. 2023 Sep 20;12(18):6086∟.
doi: 10.3390/jcm12186086∟.
PMID: 37763026∟.
Case report. ˍ
Bouffet E, Hansford JR, Garrè
ML, Hara J, Plant-Fox A, Aerts I, Locatelli F, van
der Lugt J, Papusha L, Sahm F, Tabori U, Cohen KJ, Packer RJ, Witt
O, Sandalic L, Bento Pereira
da Silva A, Russo M, Hargrave DR.
Dabrafenib
plus Trametinib
in Pediatric Glioma with BRAF
V600
Mutations.
N
Engl J Med. 2023 Sep
21;389(12):1108-1120∟.
doi: 10.1056/NEJMoa2303815∟.
PMID: 37733309∟.
Interventional study. ˍ
*
Chang IY, Tsai HC, Chen CH, Chen
HC, Huang CW, Cox GF, Huang FM, Lin YY, Chen KT,
Lin YJ, Wei KC.
CAN008
prolongs overall survival in patients with newly
diagnosed
GBM characterized by high tumor mutational burden.
Biomed
J. 2023 Sep 21:100660∟.
doi: 10.1016/j.bj.2023.100660∟.
PMID: 37741340∟.
Observational study. ˍ
Grassl N, Poschke I, Lindner K, Bunse L, Mildenberger I, Boschert
T, Jähne K, Green EW, Hülsmeyer I, Jünger S,
Kessler T, Suwala AK, Eisele P, Breckwoldt MO, Vajkoczy P, Grauer
OM, Herrlinger U, Tonn JC, Denk M, Sahm F, Bendszus M, von
Deimling A, Winkler F, Wick W, Platten M, Sahm K.
A
H3K27M-targeted vaccine in adults with diffuse midline glioma.
Nat
Med. 2023 Sep 21∟.
doi: 10.1038/s41591-023-02555-6∟.
PMID: 37735561∟.
Expanded access study. ˍ
Østergaard DE, Wahlstedt I,
Jørgensen M, Kjærsgaard M, Mathiasen R, Nysom K,
Sehested A, Vogelius IR, Maraldo
MV.
Dose-accumulation
analysis of target and organs
at risk with clinical outcome after re-irradiation of diffuse
midline glioma.
Acta
Oncol. 2023 Sep 21:1-5∟.
doi: 10.1080/0284186X.2023.2258271∟.
PMID: 37733582∟.
Observational study. ˍ
Visioli A, Trivieri N, Mencarelli G, Giani F, Copetti M, Palumbo
O, Pracella R, Cariglia MG, Barile C, Mischitelli L, Soriano AA,
Palumbo P, Legnani F, DiMeco F, Gorgoglione L, Pesole G, Vescovi
AL, Binda E.
Different states of
stemness of glioblastoma stem cells sustain glioblastoma subtypes
indicating novel clinical biomarkers and high-efficacy customized
therapies.
J Exp Clin Cancer Res. 2023 Sep
21;42(1):244∟.
doi: 10.1186/s13046-023-02811-0∟.
PMID: 37735434∟.
Laboratory investigation. ˍ
Hung ND, Anh NN, Minh ND, Huyen DK,
Duc NM.
Differentiation
of glioblastoma and primary central nervous system lymphomas using
multiparametric diffusion and perfusion magnetic resonance
imaging.
Biomed
Rep. 2023 Sep 22;19(5):82∟.
doi: 10.3892/br.2023.1664∟.
PMID: 37881606∟.
Observational study. ˍ
Lukas RV, Horbinski C.
Glioma
Response to IDH Inhibition: Real-World
Experience.
Clin
Cancer Res. 2023 Sep 22∟.
doi: 10.1158/1078-0432.CCR-23-2164∟.
PMID: 37738033∟.
Observational study˰ ˍ
*
Muench A, Teichmann D, Spille D,
Kuzman P, Perez E, May SA, Mueller WC, Kombos
T, Nazari-Dehkordi S, Onken J, Vajkoczy P, Ntoulias G, Bettencourt
C, von Deimling A, Paulus W,
Heppner FL, Koch A, Capper D, Kaul D, Thomas C, Schweizer
L.
A
Novel Type of IDH Wild-type Glioma Characterized by Gliomatosis
Cerebri-like Growth Pattern, TERT Promoter Mutation, and Distinct
Epigenetic Profile.
Am
J Surg Pathol. 2023 Sep 22∟.
doi: 10.1097/PAS.0000000000002118∟.
PMID: 37737691∟.
Observational study˰ ˍ
Ospanov A, Romanishkin I, Savelieva
T, Kosyrkova A, Shugai S, Goryaynov S, Pavlova G, Pronin I,
Loschenov V.
Optical
Differentiation of Brain Tumors Based on Raman Spectroscopy and
Cluster Analysis Methods.
Int
J Mol Sci. 2023 Sep 22;24(19):14432∟.
doi: 10.3390/ijms241914432∟.
PMID: 37833879∟.
Observational study. ˍ
Shen Y, Zheng D, Hu D, Ma B, Cai C,
Chen W, Zeng J, Luo J, Xiao D, Zhao Y, Wu Z,
Jing G, Xie Y.
The
prognostic value of tumor-associated macrophages in glioma
patients.
Medicine
(Baltimore). 2023 Sep 22;102(38):e35298∟.
doi: 10.1097/MD.0000000000035298∟.
PMID: 37747032∟.
Observational study. ˍ
Sim HW, Wachsmuth L, Barnes EH, Yip
S, Koh ES, Hall M, Jennens R, Ashley DM, Verhaak RG, Heimberger
AB, Rosenthal MA, Hovey EJ, Ellingson BM, Tognela A, Gan HK,
Wheeler H, Back M, McDonald KL, Long A, Cuff K, Begbie S, Gedye C,
Mislang A, Le H, Johnson MO, Kong BY, Simes JR, Lwin Z, Khasraw
M.
NUTMEG:
A randomized phase II study of nivolumab and temozolomide versus
temozolomide alone in newly diagnosed older patients with
glioblastoma.
Neurooncol
Adv. 2023 Sep 22;5(1):vdad124∟.
doi: 10.1093/noajnl/vdad124∟.
PMID: 37841696∟.
Interventional study. ˍ
Majós C, Pons-Escoda A,
Naval P, Güell A, Lucas A, Vidal N, Cos M, Bruna J.
Proton
MR spectroscopy shows improved performance to segregate high-grade
astrocytoma
subgroups when defined with the new 2021 World Health Organization
classification
of central nervous system tumors.
Eur
Radiol. 2023 Sep 23∟.
doi: 10.1007/s00330-023-10138-9∟.
PMID: 37740778∟.
Observational study˰ ˍ
Tiefenbach J, Toljan K, Khawam EA,
Viguera AC.
Presenting
symptoms of religious
delusions and hallucinations in temporal lobe
glioblastoma.
Psychiatr
Danub. 2023 Fall
(0923);35(3):451-453∟.
doi: 10.24869/psyd.2023.451∟.
PMID: 37917853∟.
Case report. ˍ
Fukuoka K, Kurihara J, Shofuda T,
Kagawa N, Yamasaki K, Ando R, Ishida J, Kanamori
M, Kawamura A, Park YS, Kiyotani C, Akai T, Keino D, Miyairi Y,
Sasaki A, Hirato J, Inoue T,
Nakazawa A, Koh K, Nishikawa R, Date I, Nagane M, Ichimura
K, Kanemura Y.
Subtyping
of Group 3/4 medulloblastoma as a potential prognostic
biomarker
among patients treated with reduced dose of craniospinal
irradiation: a
Japanese Pediatric Molecular Neuro-Oncology Group study.
Acta
Neuropathol Commun. 2023 Sep
25;11(1):153∟.
doi: 10.1186/s40478-023-01652-4∟.
PMID: 37749662∟.
Observational study. ˍ
Li M, Liu M, Cui Q, Zeng M, Li S,
Zhang L, Peng Y.
Effect
of dexmedetomidine on
postoperative delirium in patients undergoing awake craniotomies:
study protocol
of a randomized controlled trial.
Trials.
2023 Sep 25;24(1):607∟.
doi: 10.1186/s13063-023-07632-2∟.
PMID: 37743486∟.
Interventional study protocol.
ˍ
*
Morgacheva D, Ryzhova M, Zheludkova
O, Belogurova M, Dinikina Y.
DNA
methylation-based diagnosis confirmation in a pediatric patient
with low-grade glioma: a case report.
Front
Pediatr. 2023 Sep 25;11:1256876∟.
doi: 10.3389/fped.2023.1256876∟.
PMID: 37818165∟.
Case report. ˍ
Bjorland LS, Mahesparan R, Fluge Ø,
Gilje B, Dæhli Kurz K, Farbu E.
Impact
of extent of resection on outcome from glioblastoma using the RANO
resect group classification system: a retrospective,
population-based cohort study.
Neurooncol
Adv. 2023 Sep 26;5(1):vdad126∟.
doi: 10.1093/noajnl/vdad126∟.
PMID: 37868696∟.
Observational study. ˍ
Günerhan G, Öcal Ö,
Dağlar Z, Çağıl E, Ertuğrul Y, Belen
AD.
The
influence of glioblastoma
on patients' cognitive and demographic characteristics and
psychological
well-being of patients and caregivers: a single-centre
retrospective
study.
Psychogeriatrics.
2023 Sep 26∟.
doi: 10.1111/psyg.13029∟.
PMID: 37752061∟.
Observational study˰ ˍ
Maas RR, Soukup K, Fournier N,
Massara M, Galland S, Kornete M, Wischnewski V, Lourenco J, Croci
D, Álvarez-Prado ÁF, Marie DN, Lilja J, Marcone R,
Calvo GF, Santalla Mendez R, Aubel P, Bejarano L, Wirapati P,
Ballesteros I, Hidalgo A, Hottinger AF, Brouland JP, Daniel RT,
Hegi ME, Joyce JA.
The
local microenvironment drives activation of neutrophils in human
brain tumors.
Cell.
2023 Sep 27:S0092-8674(23)00977-7∟.
doi: 10.1016/j.cell.2023.08.043∟.
PMID: 37769657∟.
Laboratory investigation. ˍ
Remes TM, Suo-Palosaari MH,
Arikoski PM, Harila M, Koskenkorva PKT, Lähteenmäki
PM, Lönnqvist TRI, Ojaniemi MK, Pohjasniemi H, Puosi R,
Ritari N, Sirkiä KH,
Sutela AK, Toiviainen-Salo SM, Rantala HMJ, Harila
AH.
Radiotherapy-induced
vascular cognitive impairment 20 years after childhood brain
tumor.
Neuro
Oncol. 2023 Sep 27:noad186∟.
doi: 10.1093/neuonc/noad186∟.
PMID: 37758202∟.
Observational study˰ ˍ
Saijo A, Ogino H, Butowski NA,
Tedesco MR, Gibson D, Watchmaker PB, Okada K, Wang AS, Shai A,
Salazar AM, Molinaro AM, Rabbitt JE, Shahin M, Perry A, Clarke JL,
Taylor JW, Daras M, Oberheim Bush NA, Hervey-Jumper SL, Phillips
JJ, Chang SM, Hilf N, Mayer-Mokler A, Keler T, Berger MS, Okada
H.
A
combinatory vaccine with IMA950 plus varlilumab promotes effector
memory T-cell differentiation in the peripheral blood of patients
with low-grade gliomas.
Neuro
Oncol. 2023 Sep 27:noad185∟.
doi: 10.1093/neuonc/noad185∟.
PMID: 37758193∟.
Interventional study˰ ˍ
Srinivasan S, Hegde A, Nair R,
Menon G.
Medulloblastoma
with Subcutaneous Spread: A Rare Entity.
Asian
J Neurosurg. 2023 Sep 27;18(3):698-700∟.
doi: 10.1055/s-0043-1774822∟.
PMID: 38152545∟.
Case report. ˍ
van der Meer PB, Dirven L, Fiocco
M, Vos MJ, Kerkhof M, Kouwenhoven MCM, van den Bent MJ, Taphoorn
MJB, Koekkoek JAF.
Impact
of timing of antiseizure medication withdrawal on seizure
recurrence in glioma patients: a retrospective observational
study.
J
Neurooncol. 2023 Sep 27∟.
doi: 10.1007/s11060-023-04450-z∟.
PMID: 37755633∟.
Observational study. ˍ
Demetz M, Mangesius J, Krigers A,
Nevinny-Stickel M, Thomé C, Freyschlag CF, Kerschbaumer
J.
Tumor
Location Impacts the Development of Radiation Necrosis in Benign
Intracranial Tumors.
Cancers
(Basel). 2023 Sep 28;15(19):4760∟.
doi: 10.3390/cancers15194760∟.
PMID: 37835452∟.
Observational study. ˍ
*
Hu LS, D'Angelo F, Weiskittel TM,
Caruso FP, Fortin Ensign SP, Blomquist MR, Flick
MJ, Wang L, Sereduk CP, Meng-Lin K, De Leon G, Nespodzany A,
Urcuyo JC, Gonzales AC,
Curtin L, Lewis EM, Singleton KW, Dondlinger T, Anil A, Semmineh
NB, Noviello T, Patel RA, Wang P,
Wang J, Eschbacher JM, Hawkins-Daarud A, Jackson
PR, Grunfeld IS, Elrod C, Mazza GL, McGee SC, Paulson L,
Clark-Swanson K,
Lassiter-Morris Y, Smith KA, Nakaji P, Bendok BR, Zimmerman RS,
Krishna C, Patra DP, Patel
NP, Lyons M, Neal M, Donev K, Mrugala MM, Porter AB, Beeman SC,
Jensen TR, Schmainda KM, Zhou Y,
Baxter LC, Plaisier CL, Li J, Li H, Lasorella A,
Quarles CC, Swanson KR, Ceccarelli M, Iavarone A, Tran
NL.
Integrated
molecular
and multiparametric MRI mapping of high-grade glioma identifies
regional
biologic signatures.
Nat
Commun. 2023 Sep 28;14(1):6066∟.
doi: 10.1038/s41467-023-41559-1∟.
PMID: 37770427∟.
Observational study. ˍ
Ruis C, Robe PA, Dijkerman
HC.
Preserving
the ability to discriminate between
left
and right; A case study.
J
Neuropsychol. 2023 Sep 28∟.
doi: 10.1111/jnp.12348∟.
PMID: 37771271∟.
Case report. ˍ
Schaufler A, Sanin AY, Sandalcioglu
IE, Hartmann K, Croner RS, Perrakis A, Wartmann
T, Boese A, Kahlert UD, Fischer I.
Concept
of a fully-implantable system
to monitor tumor recurrence.
Sci
Rep. 2023 Sep 29;13(1):16362∟.
doi: 10.1038/s41598-023-43226-3∟.
PMID: 37773315∟.
Laboratory investigation. ˍ
Yu H, Chen M, Huang Y, Wang P, Li
J, Li Q, Jiang R.
Differential
Diagnosis of Intracranial
Malignant Tumors Using MRI Based on Morphological Features and
Signal
Intensity Ratio of Lesions.
Altern
Ther Health Med. 2023 Sep 29:AT8218∟.
PMID: 37773646∟.
Observational study. ˍ
Ertzgaard P, Nyman P, Jakobsson M,
Johansson J.
Oculomotor
screening and neuro-visual rehabilitation following pediatric
brain tumor resection.
J
Pediatr Rehabil Med. 2023 Sep 30∟.
doi: 10.3233/PRM-220127∟.
PMID: 37807791∟.
Case report. ˍ
Kanematsu R, Mizuno M, Inoue T,
Takahashi T, Endo T, Shigekawa S, Muto J, Umebayashi
D, Mitsuhara T, Hida K, Hanakita J; Investigators of
Intramedullary Spinal Cord
Tumors in the Neurospinal Society of Japan.
The
Impact of Adjuvant
Radiotherapy
on Clinical Performance Status in Patients With Grade II Spinal
Cord
Astrocytoma - A Nationwide Analysis by the Neurospinal Society of
Japan.
Neurospine.
2023 Sep 30;20(3):766-773∟.
doi: 10.14245/ns.2346386.193∟.
PMID: 37798968∟.
Observational study. ˍ
Karlberg A, Pedersen LK, Vindstad
BE, Skjulsvik AJ, Johansen H, Solheim O, Skogen K, Kvistad KA,
Bogsrud TV, Myrmel KS, Giskeødegård GF, Ingebrigtsen
T, Berntsen EM, Eikenes L.
Diagnostic
accuracy of anti-3-[18F]-FACBC
PET/MRI in gliomas.
Eur
J Nucl Med Mol Imaging. 2023 Sep 30∟.
doi: 10.1007/s00259-023-06437-4∟.
PMID: 37776502∟.
Interventional study.
ˍ
Muto J, Murata H, Shigekawa S,
Mitsuhara T, Umebayashi D, Kanematsu R, Joko M, Inoue T, Inoue T,
Endo T, Hirose Y; Investigators of Intramedullary Spinal Cord
Tumors in the Neurospinal Society of Japan.
Clinical
Characteristics and Long-term Outcomes of Spinal Pilocytic
Astrocytomas: A Multicenter Retrospective Study by the Neurospinal
Society of Japan.
Neurospine.
2023 Sep 30;20(3):774-782∟.
doi: 10.14245/ns.2346450.225∟.
PMID: 37798969∟.
Observational study. ˍ